Literature DB >> 28724126

Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals.

Taisei Kobayashi1,2, Thomas J Glorioso3,4,5,6, Ehrin J Armstrong3,4,5, Thomas M Maddox3,4,5,6, Mary E Plomondon3,4,5,6, Gary K Grunwald3,4,5,6, Steven M Bradley3,4,5, Thomas T Tsai3,4,5, Stephen W Waldo3,4,5, Sunil V Rao7,8, Subhash Banerjee9,10, Brahmajee K Nallamothu11,12, Deepak L Bhatt13,14,15, A Garvey Rene1,2, Robert L Wilensky1,2, Peter W Groeneveld1,2, Jay Giri1,2.   

Abstract

Importance: Current comparative outcomes among black and white patients treated with percutaneous coronary intervention (PCI) in the Veterans Affairs (VA) health system are not known. Objective: To compare outcomes between black and white patients undergoing PCI in the VA health system. Design, Setting, and Participants: This study compared black and white patients who underwent PCI between October 1, 2007, and September 30, 2013, at 63 VA hospitals using data recorded in the VA Clinical Assessment, Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program. A generalized linear mixed model with a random intercept for site assessed the relative difference in odds of outcomes between black and white patients. The setting was integrated institutionalized hospital care. Excluded were all patients of other races or those with multiple listed races and those with missing data regarding race or the diagnostic cardiac catheterization. The dates of analysis were January 7, 2016, to April 17, 2017. Exposure: Percutaneous coronary intervention at a VA hospital. Main Outcomes and Measures: The primary outcome was 1-year mortality. Secondary outcomes were 30-day all-cause readmission rates, 30-day acute kidney injury, 30-day blood transfusion, and 1-year readmission rates for myocardial infarction. In addition, variations in procedural and postprocedural care were examined, including the use of intravascular ultrasound, optical coherence tomography, fractional flow reserve measurements, bare-metal stents, postprocedural medications, and radial access.
Results: A total of 42 391 patients (13.3% black and 98.4% male; mean [SD] age, 65.2 [9.1] years) satisfied the inclusion and exclusion criteria. In unadjusted analyses, black patients had higher rates of 1-year mortality (7.1% vs 5.9%, P < .001) as well as secondary outcomes of 30-day acute kidney injury (20.8% vs 13.8%, P < .001), 30-day blood transfusion (3.4% vs 2.7%, P < .01), and 1-year readmission rates for myocardial infarction (3.3% vs 2.7%, P = .01) compared with white patients. After adjustment for demographics, comorbidities, and procedural characteristics, odds for 1-year mortality (odds ratio, 1.04; 95% CI, 0.90-1.19) were not different between black and white patients. There were also no differences in secondary outcomes with the exception of a higher rate of adjusted 30-day acute kidney injury (odds ratio, 1.22; 95% CI, 1.10-1.36). Conclusions and Relevance: While black patients had a higher rate of mortality than white patients in unadjusted analyses, race was not independently associated with 1-year mortality among patients undergoing PCI in VA hospitals.

Entities:  

Mesh:

Year:  2017        PMID: 28724126      PMCID: PMC5710175          DOI: 10.1001/jamacardio.2017.2180

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  45 in total

1.  Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.

Authors:  Ajay J Kirtane; Anuj Gupta; Srinivas Iyengar; Jeffrey W Moses; Martin B Leon; Robert Applegate; Bruce Brodie; Edward Hannan; Kishore Harjai; Lisette Okkels Jensen; Seung-Jung Park; Raphael Perry; Michael Racz; Francesco Saia; Jack V Tu; Ron Waksman; Alexandra J Lansky; Roxana Mehran; Gregg W Stone
Journal:  Circulation       Date:  2009-06-15       Impact factor: 29.690

Review 2.  Sleep apnea and cardiovascular disease: a bidirectional relationship.

Authors:  Takatoshi Kasai; John S Floras; T Douglas Bradley
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

3.  β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.

Authors:  Charlotte Andersson; David Shilane; Alan S Go; Tara I Chang; Dhruv Kazi; Matthew D Solomon; Derek B Boothroyd; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

4.  Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system.

Authors:  J Whittle; J Conigliaro; C B Good; R P Lofgren
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

5.  Sleep-disordered breathing and coronary artery disease: long-term prognosis.

Authors:  T Mooe; K A Franklin; K Holmström; T Rabben; U Wiklund
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

6.  Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction.

Authors:  Therese A Stukel; F Lee Lucas; David E Wennberg
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

7.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

8.  Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs.

Authors:  E D Peterson; S M Wright; J Daley; G E Thibault
Journal:  JAMA       Date:  1994-04-20       Impact factor: 56.272

9.  Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.

Authors: 
Journal:  JAMA       Date:  1982-10-22       Impact factor: 56.272

10.  Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.

Authors:  Kojiro Miki; Kenichi Fujii; Daizo Kawasaki; Masahiko Shibuya; Masashi Fukunaga; Takahiro Imanaka; Hiroto Tamaru; Akinori Sumiyoshi; Machiko Nishimura; Tetsuo Horimatsu; Ten Saita; Kozo Okada; Takumi Kimura; Yasuhiro Honda; Peter J Fitzgerald; Tohru Masuyama; Masaharu Ishihara
Journal:  J Endovasc Ther       Date:  2016-04-04       Impact factor: 3.487

View more
  8 in total

1.  Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis.

Authors:  Wayne Batchelor; David E Kandzari; Scott Davis; Luis Tami; John C Wang; Islam Othman; Osvaldo S Gigliotti; Amir Haghighat; Sarabjeet Singh; Mario Lopez; Gregory Giugliano; Phillip A Horwitz; Jaya Chandrasekhar; Paul Underwood; Craig A Thompson; Roxana Mehran
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

2.  Relation of glycemic status with unrecognized MI and the subsequent risk of mortality: The Jackson Heart Study.

Authors:  R Brandon Stacey; Michael E Hall; Paul E Leaverton; Douglas D Schocken; Janice Zgibor
Journal:  Am J Prev Cardiol       Date:  2022-05-10

3.  Racial Differences in AKI Incidence Following Percutaneous Coronary Intervention.

Authors:  Joseph Lunyera; Robert M Clare; Karen Chiswell; Julia J Scialla; Patrick H Pun; Kevin L Thomas; Monique A Starks; Clarissa J Diamantidis
Journal:  J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 10.121

4.  Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction.

Authors:  Ganesh V Halade; Vasundhara Kain; Chrisly Dillion; Mark Beasley; Tanja Dudenbostel; Suzanne Oparil; Nita A Limdi
Journal:  ESC Heart Fail       Date:  2020-05-04

5.  Disparities in Access to Revascularization: Evidence from New York.

Authors:  Michael K Gusmano; Daniel Weisz; Catherine Allende; Victor G Rodwin
Journal:  Health Equity       Date:  2019-08-28

6.  Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Anping Cai; Chrisly Dillon; William B Hillegass; Mark Beasley; Brigitta C Brott; Vera A Bittner; Gilbert J Perry; Ganesh V Halade; Sumanth D Prabhu; Nita A Limdi
Journal:  J Am Heart Assoc       Date:  2019-11-08       Impact factor: 5.501

7.  Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term Outcomes.

Authors:  Scott Kinlay; Lien Quach; Jean Cormack; Natalie Morgenstern; Ying Hou; Melissa Young; Rebecca Sherrod; Kelly Cho; David P Faxon; Ronnie Ramadan; Michael Gaziano; David Gagnon
Journal:  J Am Heart Assoc       Date:  2021-04-26       Impact factor: 6.106

Review 8.  The Effects of Race on Acute Kidney Injury.

Authors:  Muzamil Olamide Hassan; Rasheed Abiodun Balogun
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.